GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab) as the first and only immunotherapy for adults with stage II and III ...
GSK plc (LSE/NYSE: GSK) today announced that it has completed the primary objective data analysis from the phase II part of the TH HSV REC-003 trial. This trial is a combined phase I/II ...
ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi B.V. (Shionogi) as shareholders, has announced that the U.S. Food ...
Approval based on ARROS-1 phase I/II trial demonstrating meaningful and durable responses in patients with locally advanced or metastatic disease 1 Next-generation design aims to address key efficacy ...
Metastatic castration-resistant prostate cancer (mCRPC) remains a significant health burden for men with critical need for novel targeted treatments Agreement adds a new preclinical ADC with potential ...
Expanded approval includes MMRp/MSS tumours, which represent approximately 75% of endometrial cancer cases Approval based on RUBY Part 1 trial, which showed a median overall survival (OS) of 44.6 ...
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted the company’s regulatory application to expand the use of its adjuvanted recombinant respiratory syncytial ...
CureVac will make an upfront settlement of $370 million to GSK GSK will receive a 1% royalty on future Pfizer / BioNTech US sales of influenza, COVID-19 and related combination mRNA vaccine products ...
Lynn joined the Executive Committee in 2026. As President, Europe, she is responsible for the commercial performance and strategic direction of GSK’s European markets, overseeing a diverse range of ...
We work with thousands of third parties across all areas of our business. On this page we detail our third-party policies and practices. Our suppliers and other third parties – including agents, ...
We have established an enhanced information service for former residents of mother and baby homes in Ireland regarding trials that took place between 1934 and 1973 in response to the issues raised ...
GSK plc (LSE/NYSE: GSK) today announced completion of its acquisition of Nuvalent, Inc. 1, a Boston-based clinical-stage biopharmaceutical company focused on creating precisely targeted oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results